Life Stem Genetics (LIFS) Stock Price & Analysis
LIFS Stock Chart & Stats
- Day’s Range
- $0.13 - $0.13
- 52-Week Range
- $0.13 - $0.13
- Previous Close
- $0.01
- Volume
- 250
- Average Volume (3M)
- 16.15K
- Market Cap
- $24.58K
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- $0
- Price to Earnings (P/E)
- ―
- Beta
- -17.49
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
LIFS FAQ
What was Life Stem Genetics’s price range in the past 12 months?
What is Life Stem Genetics’s market cap?
When is Life Stem Genetics’s upcoming earnings report date?
Is Life Stem Genetics overvalued?
Does Life Stem Genetics pay dividends?
What is Life Stem Genetics’s EPS estimate?
How many shares outstanding does Life Stem Genetics have?
Which hedge fund is a major shareholder of Life Stem Genetics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Life Stem Genetics
Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
- Sector
- Financial
- Industry
- Biotechnology
- CEO
- Gloria Simov
- Employees
- 0
- Website
- www.lifestemgenetics.com
- Address
- 3300 Parker Lane, East Stroudsburg, PA, 18301, US